Measles virus vaccine live attenuated

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Measles virus vaccine live attenuated
Accession Number
DB10315
Description

Measles virus vaccine live attenuated is a live virus vaccine for simultaneous vaccination against measles, which is a common childhood disease. The vaccine is prepared from the attenuated line of measles virus, derived from Enders' attenuated Edmonston strain and propagated in chick embryo cell culture.

Type
Biotech
Groups
Approved, Investigational
Biologic Classification
Vaccines
Attenuated
Synonyms
  • Live attenuated measles virus (Schwartz strain)
  • Measles vaccine (live)
  • Measles virus live antigen
  • Measles virus live antigen, A
  • Measles virus strain enders' attenuated edmonston live (attenuated) antigen
  • Measles virus strain enders' attenuated edmonston live antigen
  • Measles virus vaccine live
  • Measles virus vaccine live attenuated
  • Measles Virus Vaccine Live, Enders' attenuated Edmonston strain
  • Measles virus vaccine, inactivated
  • Measles virus vaccine, live
  • Measles virus vaccine, live, attenuated
  • Measles virus vaccine,live attenuated

Pharmacology

Indication
Not Available
Associated Conditions
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Measles Virus Vacc Live Att Freez Dried InjPowder, for solutionSubcutaneousIaf Biovac Inc.1991-12-311997-08-20Canada flag
Measles Virus Vaccine Live Atten DriedPowder, for solutionSubcutaneousConnaught Laboratories Ltd.1982-12-312000-07-18Canada flag
Additional Data Available
  • Application Number
    Application Number

    A unique ID assigned by the FDA when a product is submitted for approval by the labeller.

    Learn more
  • Product Code
    Product Code

    A governmentally-recognized ID which uniquely identifies the product within its regulatory market.

    Learn more
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
M-M-R IIMeasles virus vaccine live attenuated (1000 [TCID_50]/0.5mL) + Mumps virus strain B level jeryl lynn live antigen (12500 [TCID_50]/0.5mL) + Rubella virus vaccine (1000 [TCID_50]/0.5mL)Injection, powder, lyophilized, for suspensionSubcutaneousA-S Medication Solutions1971-04-21Not applicableUS flag
M-M-R IIMeasles virus vaccine live attenuated (1000 [TCID_50]/0.5mL) + Mumps virus strain B level jeryl lynn live antigen (12500 [TCID_50]/0.5mL) + Rubella virus vaccine (1000 [TCID_50]/0.5mL)Injection, powder, lyophilized, for suspensionSubcutaneousPhysicians Total Care, Inc.1996-08-072012-06-30US flag
M-M-R IIMeasles virus vaccine live attenuated (1000 [TCID_50]/0.5mL) + Mumps virus strain B level jeryl lynn live antigen (12500 [TCID_50]/0.5mL) + Rubella virus vaccine (1000 [TCID_50]/0.5mL)Injection, powder, lyophilized, for suspensionSubcutaneousMerck Sharp & Dohme Corp.1971-04-21Not applicableUS flag
M-M-R IIMeasles virus vaccine live attenuated (1000 TCID50/0.5mL) + Mumps virus strain B level jeryl lynn live antigen (12500 TCID50/0.5mL) + Rubella virus vaccine (1000 TCID50/0.5mL)Powder, for solutionSubcutaneousMerck Ltd.1979-12-31Not applicableCanada flag
Measles Virus Vaccine, Live, Attenuated (dried)Measles virus vaccine live attenuated (1000 unit) + Water (0.6 ml)Kit; Liquid; Powder, for solutionSubcutaneousConnaught Laboratories Ltd.1996-12-112000-08-02Canada flag
PriorixMeasles virus vaccine live attenuated (103.0 CCID50/0.5mL) + Mumps virus strain B level jeryl lynn live antigen (103.7 CCID50/0.5mL) + Rubella virus vaccine (103.0 CCID50/0.5mL)Kit; Powder, for solutionIntramuscular; SubcutaneousGlaxosmithkline Inc1998-12-04Not applicableCanada flag
ProQuadMeasles virus vaccine live attenuated (1000 [TCID_50]/0.5mL) + Mumps virus strain B level jeryl lynn live antigen (20000 [TCID_50]/0.5mL) + Rubella virus vaccine (1000 [TCID_50]/0.5mL) + Varicella Zoster Vaccine (Live/attenuated) (9772 [PFU]/0.5mL)Injection, powder, lyophilized, for suspensionSubcutaneousMerck Sharp & Dohme Corp.2015-07-01Not applicableUS flag
ProQuadMeasles virus vaccine live attenuated (1000 [TCID_50]/0.5mL) + Mumps virus strain B level jeryl lynn live antigen (20000 [TCID_50]/0.5mL) + Rubella virus vaccine (1000 [TCID_50]/0.5mL) + Varicella Zoster Vaccine (Live/attenuated) (9772 [PFU]/0.5mL)Injection, powder, lyophilized, for suspensionSubcutaneousMerck Sharp & Dohme Limited2005-09-062018-08-31US flag
ProQuadMeasles virus vaccine live attenuated (3 log10 tcid50/0.5mL) + Mumps virus strain B level jeryl lynn live antigen (4.3 log10 tcid50/0.5mL) + Rubella virus vaccine (3 log10 tcid50/0.5mL) + Varicella Zoster Vaccine (Live/attenuated) (3.99 log10 tcid50/0.5mL)Powder, for solutionSubcutaneousMerck Ltd.2014-05-09Not applicableCanada flag

Categories

Drug Categories
Classification
Not classified

Chemical Identifiers

UNII
MFZ8I7277D
CAS number
Not Available

References

General References
Not Available
PubChem Substance
347910494
RxNav
804179
AHFS Codes
  • 80:12.00 — Vaccines

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4CompletedPreventionBCG Infection / Immune Response / Reaction - Vaccine1
4CompletedPreventionChickenpox / Hepatitis A / Mumps / Rubella / Rubeola1
4CompletedPreventionEncephalitis, Japanese B / Mumps / Rubella / Rubeola1
4CompletedPreventionHepatitis A Virus1
4CompletedPreventionMumps / Rubella / Rubeola2
3CompletedPreventionAcellular Pertussis / Diphtheria / Poliomyelitis / Tetanus1
3CompletedPreventionAcellular Pertussis / Diphtheria / Tetanus1
3CompletedPreventionBacterial Infections / Neisseria Meningitidis / Virus Diseases2
3CompletedPreventionBacterial Infections / Virus Diseases1
3CompletedPreventionChickenpox Vaccines / Varicella1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, powder, lyophilized, for suspensionSubcutaneous
Injection, powder, for suspensionIntramuscular; Subcutaneous1000 CCID50/0.5mL
Injection, powder, lyophilized, for solutionSubcutaneous0.5 ml
Powder, for solutionSubcutaneous
Kit; liquid; powder, for solutionSubcutaneous
Injection, powder, lyophilized, for solutionIntramuscular; Subcutaneous1000 TCID
Injection, powder, for solutionIntramuscular; Subcutaneous103 CCID50/0.5mL
Injection, powder, for solutionSubcutaneous103 CCID50/0.5mL
Kit; powder, for solutionIntramuscular; Subcutaneous
Injection, powder, lyophilized, for solutionIntramuscular; Subcutaneous10 CCID
Injection, powder, for solutionSubcutaneous10 CCID
Injection, powder, lyophilized, for solutionSubcutaneous10 CCID
Injection, powder, for suspensionIntramuscular; Subcutaneous1000 [TCID_50]/0.5mL
Injection, powder, lyophilized, for suspensionIntramuscular; Subcutaneous1000 [TCID_50]/0.5mL
Powder, for solutionSubcutaneous
Injection, powder, lyophilized, for suspensionIntramuscular; Subcutaneous3 log10/0.5ml
InjectionSubcutaneous1000 CCID50/0.5mL
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on December 01, 2015 13:03 / Updated on October 26, 2020 22:41

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates